Koers Global Cord Blood Corporation Deutsche Boerse AG
Aandelen
6CB
KYG393421030
Gezondheidszorgvoorzieningen & -diensten
Omzet 2021 | 1,16 mld. 160 mln. 148 mln. | Omzet 2022 | 1,24 mld. 172 mln. 159 mln. | Marktkapitalisatie | 2,97 mld. 410 mln. 379 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 508 mln. 70,1 mln. 64,9 mln. | Nettowinst (verlies) 2022 | 501 mln. 69,13 mln. 64,01 mln. | EV/omzet 2021 | -2,13 x |
Nettoliquiditeiten 2021 | 6,07 mld. 838 mln. 776 mln. | Nettoliquiditeiten 2022 | 6,66 mld. 919 mln. 851 mln. | EV/omzet 2022 | -2,97 x |
K/w-verhouding 2021 |
7,1
x | K/w-verhouding 2022 |
5,93
x | Werknemers | 1.202 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 38,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 01-01-09 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 01-01-09 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 01-11-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 01-01-09 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 01-01-09 |
Director/Board Member | 56 | 01-01-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,66% | 88,38 mld. | |
-21,76% | 77,56 mld. | |
+8,45% | 26,97 mld. | |
+7,94% | 18,45 mld. | |
-13,50% | 16,57 mld. | |
+77,51% | 13,65 mld. | |
+76,96% | 13,06 mld. | |
+4,72% | 12,61 mld. | |
+36,67% | 12,56 mld. |